Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Other(2)

Detailed Status

unknown2
Completed1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed125%
unknown250%
not_yet_recruiting125%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable

The MB-EAT Smart Teen Study

NCT07130838
completednot_applicable

Interned-delivered Intervention Based on Acceptance Principles

NCT05514964
unknown

Sonography and Haemophilia

NCT04550988
unknownnot_applicable

A Feasibility Study for Women Receiving Anthracycline Chemotherapy With or Without Radiation for HER2-neu Positive Invasive Ductal Carcinoma

NCT02156648

Clinical Trials (4)

Showing 4 of 4 trials
NCT07130838Not Applicable

The MB-EAT Smart Teen Study

Not Yet Recruiting
NCT05514964Not Applicable

Interned-delivered Intervention Based on Acceptance Principles

Completed
NCT04550988

Sonography and Haemophilia

Unknown
NCT02156648Not Applicable

A Feasibility Study for Women Receiving Anthracycline Chemotherapy With or Without Radiation for HER2-neu Positive Invasive Ductal Carcinoma

Unknown

All 4 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
4